The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared with daily basal insulin injections. HAMBURG, Germany -- Faster-acting insulin aspart was safe for pregnant women with type 1 or 2 diabetes and resulted in fewer events of hypoglycemia, the randomized CopenFast trial found. The mean ...

Understanding the Context

Please provide your email address to receive an email when new articles are posted on . A group of experts updated the FITTER insulin injection recommendations for the first time since 2016. The ... WebMD: Awiqli: FDA Approves First and Only Once-Weekly Long-Acting Basal Insulin for Adults With Type 2 Diabetes Awiqli: FDA Approves First and Only Once-Weekly Long-Acting Basal Insulin for Adults With Type 2 Diabetes Everyday Health on MSN: Do you still need insulin for type 2 diabetes in the Ozempic era?

Key Insights

Learn how GLP-1s are changing type 2 diabetes care, when insulin therapy is still necessary, and the benefits of combining these powerful treatments. Do you still need insulin for type 2 diabetes in the Ozempic era?